Publications

Samee’s authorship is denoted in bold;

Total citations as of Nov 2023:

• Clarivate Web of Science: 29
  
• Google Scholar: 45 (h-index = 3, i10-index = 2)

Peer reviewed

Arpita Goswami, S. Madan Kumar, Samee Ullah, Milind M. Gore 2023. De novo design of anti-variant COVID-19 vaccine. Biology Methods and Protocols, Volume 8. doi: 10.1093/biomethods/bpad021. [pdf]

Domenica Musumeci, Samee Ullah, Aamer Ikram, Giovanni N Roviello 2022. Novel insights on nucleopeptide binding: A spectroscopic and in silico investigation on the interaction of a thymine-bearing tetrapeptide with a homoadenine DNA. Journal of Molecular Liquids, Volume 347. doi: 10.1016/j.molliq.2021.117975. [pdf]

Adewale Oluwaseun Fadaka, Odunayo Anthonia Taiwo, Oluwatosin Adebisi Dosumu, Oluwafemi Paul Owolabi, Adebola Busola Ojo, Nicole Remaliah Samantha Sibuyi, Samee Ullah, Ashwil Klein, Abram Madimabe Madiehe, Mervin Meyer, Oluwafemi Adeleke Ojo 2022. Computational prediction of potential drug-like compounds from Cannabis sativa leaf extracts targeted towards Alzheimer therapy. Journal of Molecular Liquids, Volume 360. doi: https://doi.org/10.1016/j.molliq.2022.119393. [pdf]

Misbahuddin M Rafeeq, Hussam Aly Sayed Murad, Samee Ullah, Zaheer Ahmed, Qamre Alam, Muhammad Bilal, Alaa Hamed Habib, Ziaullah M Sain, Muhammad Jawad Khan, Muhammad Umair. Case report: A novel de novo loss of function variant in the DNA-binding domain of TBX2 causes severe osteochondrodysplasia. Frontiers in Genetics, Volume 13. doi: https://doi.org/10.3389/fgene.2022.1117500. [pdf]

Massab Umair, Aamer Ikram, Muhammad Salman, Muhammad Masroor Alam, Nazish Badar, Zaira Rehman, Sana Tamim, Adnan Khurshid, Abdul Ahad, Hamza Ahmad, Samee Ullah Importation of SARS‐CoV‐2 variant B. 1.1. 7 in Pakistan. Journal of Medical Virology, Volume 93. doi: https://doi.org/10.1002/jmv.26869. [pdf]

Pre-prints

Samee Ullah, Afreenish Amir, Aamer Ikram, Giovanni Nicola Roviello, Caterina Vicidomini, Rosanna Palumbo Computational insights on the destabilizing mutations in the binding site of 3CL-protease SARS-CoV-2 Omicron (VOC). bioRxiv, doi: 10.1101/2023.05.24.542061. [pdf]